O Dr. Bernd Hertenstein é especialista em transplantes de medula óssea e tratamentos de mieloma, com 32 anos de experiência em oncologia clínica.
Especializado em mieloma múltiplo e outros distúrbios hematológicos no Liv Hospital Vadistanbul, com ampla formação em hematologia e transplante de células estaminais.
Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.
He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.
He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.
O Dr. Prakash Pandit é especialista em terapias de radiação avançadas para mieloma no HCG Manavata Cancer Centre.
O onco-hematologista Ofer Spielberg trata cancros do sangue no Assuta Medical Center.
A Professora Ben-Yehuda é Chefe de Hematologia do Hadassah Medical Center e reconhecida Decana da sua Faculdade de Medicina.
Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.
He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.
Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.
His medical interests include:
Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)
Acute Leukemia
Chronic Leukemia Treatments
Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatments
Multiple Myeloma Treatments, MDS
Aplastic Anemia
ITP
TTP Treatments
Hypercoagulability
Hereditary Thrombophilia Treatments
Therapeutic Apheresis
Photopheresis
Geriatric Hematology Diseases.
Com mais de 20 anos de experiência, a Dra. Lopez Ibor lidera a Unidade de Hematologia e Oncologia Pediátrica do Hospital HM Montepríncipe, especializando-se em doenças hematológicas.
Dra. Viola Fox é a Médica Chefe da Clínica de Hematologia, Oncologia e Medicina Paliativa no BKZ Solingen. Esta clínica é um centro de câncer interdisciplinar certificado. A Dra. Fox é uma especialista de destaque em terapia medicamentosa para doenças tumorais na Alemanha e na Europa. Ela tem mais de 15 anos de experiência nesta área.
Ela é membro da Sociedade Alemã de Oncologia e Hemato-oncologia (GDHO), da Associação Alemã de Médicos e da American Association for Cancer Research. A Dra. Fox também é ativa na pesquisa em biologia molecular. Seu trabalho apoia o progresso no tratamento do câncer e nos diagnósticos moleculares.
As suas principais áreas de especialização são a quimioterapia, a imunoterapia, a terapia alvo e a radioterapia. A Dra. Fox é conhecida por seus métodos inovadores e forte compromisso com o cuidado ao paciente. Seus esforços levaram a altas taxas de recuperação e reconhecimento de seus pares.
Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.
Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.
A Prof. Dra. Sebnem Izmir Guner lidera unidades de hematologia e é especialista em mieloma múltiplo, com um forte foco em transplante de medula óssea.
Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.
Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.
Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.
1- Clínica de Oncologia Pediátrica do SSI Hospital de Tepecik (1990)
2- Unidade de Transplante de Medula Óssea Pediátrica do SSI Hospital de Tepecik (1992)
3- Unidade de Transplante de Medula Óssea Pediátrica da Faculdade de Medicina da UE (1998)
4- FUNDADOR do JOURNAL OF PEDIATRIC RESEARCH, 2014; foi feita a aplicação SCI em 2022.
1. Unidade de Transplante de Medula Óssea Pediátrica do İzmir BUÇH EAH (2019)
2. Unidade de Transplante de Medula Óssea Pediátrica do Ümraniye EAH (2020)
3. Unidade de Transplante de Medula Óssea Pediátrica do Kanuni Sultan Süleyman EAH (2020) (Transferida para Çam Sakura EAH)
Kansoy S. "Transplante de Medula Óssea e Células-Tronco Saúde Infantil e Doenças, 1ª edição, Casa de Impressão da Faculdade de Medicina da UE, 1999, Izmir
Kansoy S. Transplante de Medula Óssea na Talassemia Major III. Livro dos Dias de Talassemia do Egeu, 2000, Izmir
Kansoy S. Padrões da Pediatria KIT na Turquia. Leucemias Agudas da Infância, Antalya 2000: 73-5
Kansoy S. Efeitos tardios em crianças. Edição especial do Jornal de Transplante de Medula Óssea Clínicas Turcas. 2003
Kansoy S. Aplicações de Células-Tronco em Transplante de Medula Óssea e Células-Tronco. Livro do Curso de Enfermagem Oncológica Pediátrica, İzmir, 2005
Kansoy S. Sangue do Cordão Umbilical como Fonte de Células-Tronco. Edição Especial de Células-Tronco. Clínicas da Turquia, 2008
Kansoy S. Transplante de Células-Tronco em Linfomas. Livro de Pediatria Geral, Ed. Prof.Dr.Enver Hasanoglu, 2009
Kansoy S, Aksoylar S. Transplante de Medula Óssea em Crianças. Pediatria, 2014 e 2017
Kansoy S. Rabdomiossarcoma. Pediatria, 2014 e 2017
Kansoy S. Abordagem à criança com câncer de acordo com os achados clínicos. Pediatria, 2014 e 2017
11. Çetingül N, S.Kansoy, M.Kantar. Doenças Oncológicas. Pediatria (Ed. A. Cura), 641-672, Casa de Impressão da Universidade de Ege, Izmir, 1999. (1,05 pontos)
Kansoy S, M.Kantar. Exame de Cabeça, Face e Olho. Exame Físico Prosético Pediátrico e Informação de Sintomas (Ed. A.Cura)
Kantar M. Problemas de Emergência Metabólica em Oncologia. Emergências Oncológicas e Cuidados de Apoio na Infância (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, Izmir, 2003.
Transplantes de Sangue do Cordão Umbilical na Turquia. HEMATOLOGISTA, 2016
Kansoy S. Tumores do Sistema Nervoso Central em Crianças Pediatria, 2014 e 2017
Leucemia Mieloblástica Aguda em Crianças e seu Tratamento. Livro Textbook de Oncologia Pediátrica, Turco de Poplack, 2020
Atividade nacional de transplante de células-tronco pediátrico, 2020
Indicações de transplante de células-tronco na infância, Clínicas da Turquia - Livro Internacional 2020
Além dos estudos e artigos em revistas internacionais publicadas em grande número, ele está envolvido em estudos multicêntricos internacionais em algumas revistas com alto valor de impacto.
Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.
He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.
He received his Doctor of Medicine degree from the University of Barcelona in 2002.
Dr. Kobo continues his research and has been awarded grants:
•Interdepartmental Commission for Innovation of the Generalitat de Catalunya
•Scholarship Fund Universitaria Agustí Pedro i Pons
•Farreras Valentí & Schering Plough School of Hematology Scholarship
•Award for the best report at the Council of the Spanish Hematology Association
•Grant from the Catalan Society of Hematology
Specialization:
•Lymphoma
•Acute leukemia
•Chronic leukemia
•Autoimmune pancytopenia
| Médico | experiência | Bom para | O que os diferencia | Clínica e localização | Consulta |
|---|---|---|---|---|---|
| Pacientes de transplante de medula óssea | Especialista em transplantes de medula óssea autólogos e alogénicos – incluindo de dadores aparentados e não aparentados. Experiência em protocolos avançados de tratamento de mieloma. | Alemanha | Preço sob consulta | ||
| 36 anos de experiência | Mieloma múltiplo | Especializar-se em mieloma com experiência em transplante de células estaminais e aférese terapêutica. Exercer cargos de liderança académica em hematologia e medicina interna. | Turquia | Preço sob consulta | |
| 35 anos de experiência | Radioterapia avançada | Especialista em técnicas de radiação de ponta, como Tomotherapy-H e Braquiterapia. Consultor no HCG Manavata Cancer Centre. | Índia | Preço sob consulta | |
| Tratamento do mieloma | Especializa-se exclusivamente em mieloma e cancros do sangue, tratando pacientes numa rede de hospitais privados líder em Israel. | Israel | Preço sob consulta | ||
| 34 anos de experiência | Mieloma complexo e transplante de medula óssea | Liderou o departamento de hematologia por mais de 20 anos e foi pioneiro na pesquisa de terapia genética. Diretor da Faculdade de Medicina Hadassah e vencedor do prêmio «Healing with the Heart». | Israel | Preço sob consulta | |
| 32 anos de experiência | Doenças hematológicas pediátricas | Especializado em hematologia e oncologia pediátrica com foco em doenças hematológicas. Dirige uma unidade dedicada no Hospital HM Montepríncipe. | Espanha | Preço sob consulta | |
| 33 anos de experiência | Mieloma múltiplo & transplante de medula óssea | Fundador de vários centros de transplante de medula óssea – especialista líder no tratamento do mieloma. Pesquisador premiado com mais de 19 publicações internacionais. | Turquia | Preço sob consulta |